These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9055134)

  • 1. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T
    J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and simple method for estimating metildigoxin dosing regimens by multiple trough screen analysis.
    Yukawa E
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):605-11. PubMed ID: 8688985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Mine H; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1992 Sep; 44(9):761-5. PubMed ID: 1360530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    Drugs Aging; 2011 Oct; 28(10):831-41. PubMed ID: 21970310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic investigation of digoxin in Japanese infants and young children.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    J Clin Pharmacol; 2011 Jun; 51(6):857-63. PubMed ID: 20592416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T
    Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H
    Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics of Digoxin in Duchenne Muscular Dystrophy (DMD) Patients.
    Tateishi M; Ebihara A
    Am J Ther; 1994 Aug; 1(2):144-149. PubMed ID: 11835079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Nomiyama N; Higuchi S; Aoyama T
    Ther Drug Monit; 1993 Apr; 15(2):75-82. PubMed ID: 8503142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population analysis for the optimization of digoxin treatment in Japanese paediatric patients.
    Suematsu F; Minemoto M; Yukawa E; Higuchi S
    J Clin Pharm Ther; 1999 Jun; 24(3):203-8. PubMed ID: 10438180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?
    Cohen E; Almog S; Staruvin D; Garty M
    Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization.
    EL Desoky ES; Nagaraja NV; Derendorf H
    Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
    Kothare PA; Soon DK; Linnebjerg H; Park S; Chan C; Yeo A; Lim M; Mace KF; Wise SD
    J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients.
    Choi SA; Yun HY; Lee ES; Shin WG
    Clin Ther; 2014 Mar; 36(3):389-400. PubMed ID: 24612944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice.
    Zhou XD; Gao Y; Guan Z; Li ZD; Li J
    Acta Pharmacol Sin; 2010 Jun; 31(6):753-8. PubMed ID: 20523346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of itraconazole on digoxin clearance in patients with congestive heart failure].
    Wakasugi H; Ishizuka R; Koreeda N; Yano I; Futami T; Nohara R; Sasayama S; Inui K
    Yakugaku Zasshi; 2000 Sep; 120(9):807-11. PubMed ID: 11019654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of digoxin in elderly patients.
    Chen R; Zou SL; Wang ML; Jiang Y; Xue H; Qian CY; Xia ZL
    Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):115-21. PubMed ID: 23096939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.